MG

Mahasivabattu Gowtham Tej

Active Director Director DIN 11178069
DIN 11178069 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahasivabattu Gowtham Tej

Data last updated:

Mahasivabattu Gowtham Tej is a Director at Skiniii Poly Clinic Private Limited (since 2025). The company operates in Healthcare.

DIN 11178069
Primary Designation Director
Industry Healthcare
First Appointment 01 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skiniii Poly Clinic Private Limited U20237TS2025PTC200567
Director01 Jul 20252025Active

Board colleagues of Mahasivabattu Gowtham Tej

NameDINCompanyDesignation
Rekha Pratyusha Jampana07637323Skiniii Poly Clinic Private LimitedDirector

Directorship timeline

Open interactive timeline →
Skiniii Poly Clinic Private Limited
Premium access

Shareholding and investment profile for Mahasivabattu Gowtham Tej

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahasivabattu Gowtham Tej

Mahasivabattu Gowtham Tej currently holds 1 directorship: Skiniii Poly Clinic Private Limited (Director, since 01 Jul 2025).

Mahasivabattu Gowtham Tej was first appointed on 01 Jul 2025 as Director at Skiniii Poly Clinic Private Limited.

The current boards of Mahasivabattu Gowtham Tej's companies include Rekha Pratyusha Jampana (Skiniii Poly Clinic Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available